SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?


To: NTTG who wrote (11566)10/11/2012 10:48:17 AM
From: Howard Williams  Read Replies (1) | Respond to of 13111
 
>>Guess the PV-10 silver bullet hypothesis is dead now?<<

........ or it got gold plated .........

Combo deal ......... :-)

GLTA!



To: NTTG who wrote (11566)10/11/2012 11:10:54 AM
From: jm2i123  Respond to of 13111
 
PVCT is ready to embark on a Phase 3 clinical trial, which is being waited for or at least watched by then entire Melanoma world experts community, if not the entire Cancer community, with Pfizer, that will propell the company to multi billion dollar status.

and you, are telling us.. what are you telling us?...

that combination opportunities will be made available before Pvct has any data?

Do you know the profile of this SPA?